{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:18:48Z","timestamp":1784204328250,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018696","name":"R\u00e9gion Normandie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015519","name":"Universit\u00e9 de Caen Normandie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"La Ligue Contre Le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtn.2025.102642","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T06:53:54Z","timestamp":1753253634000},"page":"102642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring adenosine analogs for chondrosarcoma therapy: In vitro and in vivo insights"],"prefix":"10.1016","volume":"36","author":[{"given":"Marion","family":"Lent\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Aury-Landas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdia","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Bernay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lhuissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Boum\u00e9diene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5642-998X","authenticated-orcid":false,"given":"Catherine","family":"Baug\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102642_bib1","article-title":"Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas","volume":"43","author":"Wood","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.omtn.2025.102642_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/0284186X.2023.2177975","article-title":"The national incidence of chondrosarcoma of bone; a review","volume":"62","author":"Thorkildsen","year":"2023","journal-title":"Acta Oncol."},{"key":"10.1016\/j.omtn.2025.102642_bib3","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3389\/fimmu.2018.01697","article-title":"Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy","volume":"9","author":"Yin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2025.102642_bib4","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","article-title":"Purine metabolism regulates DNA repair and therapy resistance in glioblastoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102642_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253170","article-title":"Clofarabine induces ERK\/MSK\/CREB activation through inhibiting CD99 on Ewing sarcoma cells","volume":"16","author":"Sevim","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102642_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13048-022-01022-z","article-title":"Targeting purine metabolism in ovarian cancer","volume":"15","author":"Liu","year":"2022","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.omtn.2025.102642_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ccell.2019.10.007","article-title":"Adenosine Metabolism: Emerging Concepts for Cancer Therapy","volume":"36","author":"Boison","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2025.102642_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098176","article-title":"3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells","volume":"9","author":"Girard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102642_bib9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.33594\/000000168","article-title":"The Antitumoral Effect of the S-Adenosylhomocysteine Hydrolase Inhibitor, 3-Deazaneplanocin A, is Independent of EZH2 but is Correlated with EGFR Downregulation in Chondrosarcomas | Cell Physiol Biochem","volume":"53","author":"Aury-Landas","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.omtn.2025.102642_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12885-017-3478-z","article-title":"Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas","volume":"17","author":"Lhuissier","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omtn.2025.102642_bib11","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.3390\/cancers13184648","article-title":"Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas","volume":"13","author":"Lhuissier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omtn.2025.102642_bib12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/106002809202600718","article-title":"Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia","volume":"26","author":"Kane","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.omtn.2025.102642_bib13","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/cncr.21005","article-title":"The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog","volume":"103","author":"Faderl","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.omtn.2025.102642_bib14","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1182\/blood-2010-02-246140","article-title":"Beyond hairy cell: the activity of cladribine in other hematologic malignancies","volume":"116","author":"Sigal","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2025.102642_bib15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3109\/10428194.2012.726722","article-title":"The role of clofarabine in acute myeloid leukemia","volume":"54","author":"Ghanem","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.omtn.2025.102642_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2017.07.023","article-title":"Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a","volume":"812","author":"Uchiyama","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102642_bib17","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1021\/jacs.9b00241","article-title":"Identification of the Formycin A Biosynthetic Gene Cluster from Streptomyces kaniharaensis Illustrates the Interplay between Biological Pyrazolopyrimidine Formation and de novo Purine Biosynthesis","volume":"141","author":"Wang","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2025.102642_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/JVI.02444-13","article-title":"Discovery of Novel Ribonucleoside Analogs with Activity against Human Immunodeficiency Virus Type 1","volume":"88","author":"Dapp","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102642_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00277-018-3562-8","article-title":"Cladribine in the remission induction of adult acute myeloid leukemia: where do we stand?","volume":"98","author":"Qasrawi","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.omtn.2025.102642_bib20","first-page":"65","article-title":"The effects of clofarabine in ALL inhibition through DNA methylation regulation","volume":"67","author":"Kaufman-Szymczyk","year":"2020","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.omtn.2025.102642_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/14796694.2.2.169","article-title":"Pentostatin and Purine Analogs For Indolent Lymphoid Malignancies","volume":"2","author":"Ho","year":"2006","journal-title":"Future Oncol."},{"key":"10.1016\/j.omtn.2025.102642_bib22","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1111\/jcmm.13864","article-title":"Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms","volume":"22","author":"Kutryb-Zajac","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.omtn.2025.102642_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115244","article-title":"Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability","volume":"251","author":"Balaraman","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.omtn.2025.102642_bib24","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/s41388-017-0080-4","article-title":"Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99","volume":"37","author":"\u00c7elik","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2025.102642_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2009.07668.x","article-title":"Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis","volume":"145","author":"Else","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omtn.2025.102642_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mayocp.2011.09.001","article-title":"My treatment approach to hairy cell leukemia","volume":"87","author":"Naik","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.omtn.2025.102642_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/10428194.2011.570394","article-title":"Mechanism of action of pentostatin and cladribine in hairy cell leukemia","volume":"52","author":"Johnston","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.omtn.2025.102642_bib28","first-page":"1329","article-title":"Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs","volume":"34","author":"Bagley","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omtn.2025.102642_bib29","doi-asserted-by":"crossref","first-page":"38367","DOI":"10.18632\/oncotarget.9525","article-title":"Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs","volume":"7","author":"Starczewska","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2025.102642_bib30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bcp.2009.06.094","article-title":"Mechanisms of anti-cancer action and pharmacology of clofarabine","volume":"78","author":"Zhenchuk","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102642_bib31","first-page":"6335","article-title":"Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias","volume":"9","author":"Gandhi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2025.102642_bib32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/cancers17060951","article-title":"ASPH Is a Metastatic Factor and Therapeutic Target in Chondrosarcoma","volume":"17","author":"Sun","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omtn.2025.102642_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105090","article-title":"A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma","volume":"102","author":"Rey","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2025.102642_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107222","article-title":"Application of patient derived xenograft model in personalized drug screening for chondrosarcoma of head and neck: A preclinical study","volume":"162","author":"Hua","year":"2025","journal-title":"Oral Oncol."},{"key":"10.1016\/j.omtn.2025.102642_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00003086-200007000-00038","article-title":"Interstitial Collagenase Gene Expression Correlates With In Vitro Invasion in Human Chondrosarcoma","volume":"376","author":"Scully","year":"2000","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.omtn.2025.102642_bib36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/01.LAB.0000073131.34648.EA","article-title":"Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin","volume":"83","author":"Gil-Benso","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.omtn.2025.102642_bib37","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1038\/s41598-017-06913-6","article-title":"Anti-inflammatory and chondroprotective effects of the S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin A, in human articular chondrocytes","volume":"7","author":"Aury-Landas","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102642_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12906-021-03435-7","article-title":"The benefit of combining curcumin, bromelain and harpagophytum to reduce inflammation in osteoarthritic synovial cells","volume":"21","author":"Brochard","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.omtn.2025.102642_bib39","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/pmic.201400436","article-title":"Gel-aided sample preparation (GASP)\u2014A simplified method for gel-assisted proteomic sample generation from protein extracts and intact cells","volume":"15","author":"Fischer","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.omtn.2025.102642_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2025.102642_bib40","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125001969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125001969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:41:15Z","timestamp":1777322475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125001969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2162253125001969"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102642","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring adenosine analogs for chondrosarcoma therapy: In vitro and in vivo insights","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102642"}}